Advertisement
Screener

ImmuCell Corporation (ICCC) Increase (Decrease) in Prepaid Expense

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Increase (Decrease) in Prepaid Expense

ImmuCell Corporation (ICCC) reported Increase (Decrease) in Prepaid Expense of $64.16 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2017-11-13

  • ImmuCell Corporation increase (decrease) in prepaid expense for the quarter ending 2017-09-30 was $178.14K.
  • ImmuCell Corporation increase (decrease) in prepaid expense for the quarter ending 2017-06-30 was -$173.75K, a 504.51% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in prepaid expense for the quarter ending 2017-03-31 was $59.77K, a 14.99% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in prepaid expense for the quarter ending 2016-12-31 was -$70.56K.
  • ImmuCell Corporation increase (decrease) in prepaid expense for fiscal 2016 was -$56.69K, a 212.76% decline from fiscal 2015.
  • ImmuCell Corporation increase (decrease) in prepaid expense for fiscal 2015 was $50.28K.
  • ImmuCell Corporation increase (decrease) in prepaid expense for fiscal 2014 was -$26.00K.
Period endIncrease (Decrease) in Prepaid Expense 3 monthIncrease (Decrease) in Prepaid Expense 6 monthIncrease (Decrease) in Prepaid Expense 9 monthIncrease (Decrease) in Prepaid Expense 12 month
2017-09-30$178.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$4.39K
derived: sum of 2 quarters · filed 2017-11-13
$64.16K
10-Q · filed 2017-11-13
-$6.40K
derived: sum of 4 quarters · filed 2017-11-13
2017-06-30-$173.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$113.99K
10-Q · filed 2017-08-14
-$184.54K
derived: sum of 3 quarters · filed 2017-08-14
-$283.94K
derived: sum of 4 quarters · filed 2017-08-14
2017-03-31$59.77K
10-Q · filed 2017-05-11
-$10.79K
derived: sum of 2 quarters · filed 2017-05-11
-$110.18K
derived: sum of 3 quarters · filed 2017-05-11
-$67.23K
derived: sum of 4 quarters · filed 2017-05-11
2016-12-31-$70.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
-$169.95K
derived: sum of 2 quarters · filed 2017-03-30
-$127.00K
derived: sum of 3 quarters · filed 2017-03-30
-$56.69K
10-K · filed 2017-03-30
2016-09-30-$99.39K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$56.44K
derived: sum of 2 quarters · filed 2016-11-10
$13.86K
10-Q · filed 2016-11-10
-$37.37K
derived: sum of 4 quarters · filed 2016-11-10
2016-06-30$42.95K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$113.26K
10-Q · filed 2016-08-11
$62.03K
derived: sum of 3 quarters · filed 2016-08-11
$23.60K
derived: sum of 4 quarters · filed 2016-08-11
2016-03-31$70.30K
10-Q · filed 2016-05-11
$19.07K
derived: sum of 2 quarters · filed 2016-05-11
-$19.36K
derived: sum of 3 quarters · filed 2016-05-11
$90.36K
derived: sum of 4 quarters · filed 2016-05-11
2015-12-31-$51.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$89.66K
derived: sum of 2 quarters · filed 2016-03-25
$20.05K
derived: sum of 3 quarters · filed 2016-03-25
$50.28K
10-K · filed 2016-03-25
2015-09-30-$38.43K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$71.29K
derived: sum of 2 quarters · filed 2015-11-12
$101.51K
10-Q · filed 2015-11-12
2015-06-30$109.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$139.94K
10-Q · filed 2015-08-13
2015-03-31$30.22K
10-Q · filed 2015-05-12
2014-12-31-$26.00K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92